Browsing by Subject "Parkinson’s disease"
Now showing items 1-9 of 9
-
AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
( Multidisciplinary Digital Publishing Institute (MDPI) , 2022 , Article)Protein damage by glycation, oxidation and nitration is a continuous process in the physiological system caused by reactive metabolites associated with dicarbonyl stress, oxidative stress and nitrative stress, respectively. ... -
Cognitive status and sleep quality can explain the fear of falling and fall history in people with Parkinson's disease.
( Lippincott, Williams & Wilkins , 2023 , Article)Fear of falling (FOF) is highly prevalent in people with Parkinson's disease (PwPD) and contributes to high fall risk. Studies reporting on the relationship between falls, FOF, and non-motor factors such as cognitive ... -
Design and efficiency evaluation of a new wearable device for multi-degree suppression of hand pathological tremor
( SAGE , 2023 , Article)Sufferers of onset upper limb tremors find difficulty performing daily tasks due to rapid involuntary movements. Traditional treatments being offered help alleviate symptoms but are costly and can be invasive. Wearable ... -
Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
( BMC , 2020 , Article)Recent studies indicated that seeded fibril formation and toxicity of α-synuclein (α-syn) play a main role in the pathogenesis of certain diseases including Parkinson's disease (PD), multiple system atrophy, and dementia ... -
Monoamine oxidase inhibitors extracted from tobacco smoke as neuroprotective factors for potential treatment of Parkinson’s disease
( Bentham Science Publishers B.V. , 2015 , Article)Parkinson’s disease (PD) is a neurodegenerative disease characterized by the loss of mainly the nigrostriatal dopaminergic neurons, which leads to motor dysfunction. Although, most of the drugs are currently used for ... -
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
( BioMed Central , 2016 , Article)Background Despite decades of intensive research, to date, there is no accepted diagnosis for Parkinson’s disease (PD) based on biochemical analysis of blood or CSF. However, neurodegeneration in the brains of PD patients ... -
Parkinson’s Disease Diagnosis Using Laplacian Score, Gaussian Process Regression and Self-Organizing Maps
( MDPI , 2023 , Article)Parkinson’s disease (PD) is a complex degenerative brain disease that affects nerve cells in the brain responsible for body movement. Machine learning is widely used to track the progression of PD in its early stages by ... -
Translation, cultural adaptation and validation of the Arabic version of the king’s Parkinson’s disease pain scale
( Taylor & Francis , 2023 , Article)Purpose: Pain in Parkinson’s disease (PD) is a highly prevalent non-motor symptom occurring in this population. The King’s PD Pain Scale (KPPS) was developed to assess pain in people with PD. This study aimed to provide a ... -
Western and ketogenic diets in neurological disorders: can you tell the difference?
( International Life Sciences Institute , 2022 , Article)The prevalence of obesity tripled worldwide between 1975 and 2016, and it is projected that half of the US population will be overweight by 2030. The obesity pandemic is attributed, in part, to the increasing consumption ...